The catalytically active serine protease domain of human complement factor I

Biochemistry

Volumn 44, Issue 16, 2005, Pages 6239-6249

  Tsiftsoglou, Stefanos A ^a   Willis, Antony C ^a   Li, Pengyun ^a,b   Chen, Xuehui ^a,b   Mitchell, Daniel A ^a   Rao, Zihe ^b   Sim, Robert B ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b TSINGHUA UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CATALYSIS; ENZYME INHIBITION; SUBSTRATES; TERNARY SYSTEMS;

CLEAVAGE; SERINE; TERNARY COMPLEX;

PROTEINS;

4 (2 AMINOETHYL)BENZENESULFONYL FLUORIDE; ANTIPAIN; COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H; COMPLEMENT FACTOR I; OPSONIN; SERINE PROTEINASE;

AFFINITY CHROMATOGRAPHY; ANTIBODY AFFINITY; ARTICLE; CATALYSIS; ENZYME ACTIVE SITE; ENZYME SPECIFICITY; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PURIFICATION; RADIOIODINATION; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; BINDING SITES; CHROMATOGRAPHY, AFFINITY; COMPLEMENT C3B; FIBRINOGEN; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PLASMIN; PROTEIN STRUCTURE, TERTIARY; SERINE ENDOPEPTIDASES;

EID: 17644364064     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi047680t     Document Type: Article

References (39)

1. Carroll, M. C. (2004) The complement system in regulation of adaptive immunity, Nat. Immunol. 5, 981-986.
2. Arlaud, G. J., Volanakis, J. E., Thielens, N. M., Narayana, S. V., Rossi, V., and Xu, Y. (1998) The atypical serine proteases of the complement system, Adv. Immunol. 69, 249-307.
3. Sim, R. B., and Tsiftsoglou, S. A. (2004) Proteases of the complement system, Biochem. Soc. Trans. 32, 21-27.
4. McAleer, M. A., and Sim, R. B. (1993) Activators and Inhibitors of Complement (Sim, R. B., Ed.) pp 1-15, Kluwer Academic Publishers, Dordrecht.
5. Law, S. K. A., and Reid, K. B. M. (1995) Complement, 2nd ed., IRL Press Ltd., Oxford.
6. Ezekowitz, R. A. (2002) Local opsonization for apoptosis?, Nat. Immunol. 3, 510-512.
7. Hart, S. P., Smith, J. R., and Dransfield, I. (2004) Phagocytosis of opsonized apoptotic cells: roles for 'old-fashioned' receptors for antibody and complement, Clin. Exp. Immunol. 135, 181-185.
8. Soames, C. J., and Sim, R. B. (1997) Interactions between human complement components factor H, factor I and C3b, Biochem. J. 326, 553-561.
9. DiScipio, R. G. (1992) Ultrastructures and interactions of complement factors H and I, J. Immunol. 149, 2592-2599.
10. Tsiftsoglou, S. A., and Sim, R. B. (2004) Human complement factor I does not require cofactors for cleavage of synthetic substrates, J. Immunol. 173, 367-375.
11. Minta, J., and Fung, M. (1999) Transcriptional modulation of the human complement factor I gene in Hep G2 cells by protein kinase C activation, Mol. Cell. Biochem. 201, 111-123.
12. Catterall, C. F., Lyons, A., Sim, R. B., Day, A. J., and Harris, T. J. (1987) Characterization of primary amino acid sequence of human complement control protein factor I from an analysis of cDNA clones, Biochem. J. 242, 849-856.
13. Goldberger, G., Bruns, G. A., Rits, M., Edge, M. D., and Kwiatkowski, D. J. (1987) Human complement factor I: analysis of cDNA-derived primary structure and assignment of its gene to chromosome 4, J. Biol. Chem. 262, 10065-10071.
14. Goldberger, G., Arnaout, M. A., Aden, D., Kay, R., Rits, M., and Colten, H. R. (1984) Biosynthesis and postsynthetic processing of human C3b/C4b inactivator (factor I) in three hepatoma cell lines, J. Biol. Chem. 259, 6492-6497.
15. Ritchie, G. E., Moffatt, B. E., Sim, R. B., Morgan, B. P., Dwek, R. A., and Rudd, P. M. (2002) Glycosylation and the complement system, Chem. Rev. 102, 305-319.
16. Kunnath-Muglia, L. M., Chang, G. H., Sim, R. B., Day, A. J., and Ezekowitz, R. A. (1993) Characterization of Xenopus laevis complement factor I structure-conservation of modular structure except for an unusual insert not present in human factor I, Mol. Immunol. 30, 1249-1256.
17. Schlott, B., Wohnert, J., Icke, C., Hartmann, M., Ramachandran, R., Guhrs, K. H., Glusa, E., Flemming, J., Gorlach, M., Grosse, F., and Ohlenschlager, O. (2002) Interaction of Kazal-type inhibitor domains with serine proteinases: biochemical and structural studies, J. Mol. Biol. 318, 533-546.
18. Chamberlain, D., Ullman, C. G., and Perkins, S. J. (1998) Possible arrangement of the five domains in human complement factor I as determined by a combination of X-ray and neutron scattering and homology modeling, Biochemistry 37, 13918-13929.
19. Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature 227, 680-685.
20. Fairbanks, G., Steck, T. L., and Wallach, D. F. (1971) Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane, Biochemistry 10, 2606-2617.
21. Matsudaira, P. (1987) Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes, J. Biol. Chem. 262, 10035-10038.
22. Sim, R. B., Day, A. J., Moffatt, B. E., and Fontaine, M. (1993) Complement factor I and cofactors in control of complement system convertase enzymes, Methods Enzymol. 223, 13-35.
23. Sim, E., and Sim, R. B. (1983) Enzymic assay of C3b receptor on intact cells and solubilized cells, Biochem. J. 210, 567-576.
24. Khan, A. R., and James, M. N. (1998) Molecular mechanisms for the conversion of zymogens to active proteolytic enzymes, Protein Sci 7, 815-836.
25. Stroud, R. M., Kossiakoff, A. A., and Chambers, J. L. (1977) Mechanisms of zymogen activation, Annu. Rev. Biophys. Bioeng. 6, 177-193.
26. Freer, S. T., Kraut, J., Robertus, J. D., Wright, H. T., and Xuong, N. H. (1970) Chymotrypsinogen: 2.5-angstrom crystal structure, comparison with alpha-chymotrypsin, and implications for zymogen activation, Biochemistry 9, 1997-2009.
27. Kossiakoff, A. A., Chambers, J. L., Kay, L. M., and Stroud, R. M. (1977) Structure of bovine trypsinogen at 1.9 Å resolution, Biochemistry 16, 654-664.
28. Reiling, K. K., Krucinski, J., Miercke, L. J., Raymond, W. W., Caughey, G. H., and Stroud, R. M. (2003) Structure of human pro-chymase: a model for the activating transition of granule-associated proteases, Biochemistry 42, 2616-2624.
29. Perkins, S. J., and Smith, K. F. (1993) Identity of the putative serine-proteinase fold in proteins of the complement system with nine relevant crystal structures, Biochem. J. 295 (Part 1), 109-114.
30. Sim, E., Wood, A. B., Hsiung, L. M., and Sim, R. B. (1981) Pattern of degradation of human complement fragment, C3b, FEBS Lett. 132, 55-60.
31. Harrison, R. A., and Lachmann, P. J. (1980) The physiological breakdown of the third component of human complement, Mol. Immunol. 17, 9-20.
32. Seya, T., and Nagasawa, S. (1988) Heat-induced thiol-disulfide interchange reaction on the third component of human complement, C3, J. Biochem. (Tokyo) 103, 792-796.
33. Davis, A. E., III, and Harrison, R. A. (1982) Structural characterization of factor I mediated cleavage of the third component of complement, Biochemistry 21, 5745-5749.
34. Sahu, A., and Lambris, J. D. (2001) Structure and biology of complement protein C3, a connecting link between innate and acquired immunity, Immunol. Rev. 180, 35-48.
35. Vassiliou, G. (1997) Pharmacological concentrations of suramin inhibit the binding of alpha2-macroglobulin to its cell-surface receptor, Eur. J. Biochem. 250, 320-325.
36. Vassiliou, G., Benoist, F., Lau, P., Kavaslar, G. N., and McPherson, R. (2001) The low-density lipoprotein receptor-related protein contributes to selective uptake of high-density lipoprotein cholesteryl esters by SW872 liposarcoma cells and primary human adipocytes, J. Biol. Chem. 276, 48823-48830.
37. Cutting, W. C. (1964) Handbook of Pharmacology, Appleton-Century-Crofts, New York.
38. Cadene, M., Duranton, J., North, A., Si-Tahar, M., Chignard, M., and Bieth, J. G. (1997) Inhibition of neutrophil serine proteinases by suramin, J. Biol. Chem. 272, 9950-9955.
39. Saez, C., Thielens, N. M., Bjes, E. S., and Esser, A. F. (1999) Association of terminal complement proteins in solution and modulation by suramin, Biochemistry 38, 6807-6816.